TORONTO, Feb. 4, 2013 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company") announced several important achievements
as it proceeds with its restructuring plan:
BIOSIGN APPOINTS SALES AGENT TO THE CANADIAN DENTAL MARKET. Dominion Medical Supply Inc ("Dominion"), a Dunville, ON-based
specialty medical/dental sales agent, has been appointed to represent
Biosign products to the Canadian dental market. Dominion represents a
number of high-tech products, including disposable supplies as well as
specialized magnifying lenses, to dentists in Ontario, Quebec and the
Maritimes. The advanced nature of the products sold by Dominion
typically involves extended interview time on each sales call to
dentist and dental hygienist customers, which positions Dominion's team
to detail the benefits offered by Biosign's health monitoring products.
BIOSIGN & DOMINION RE-LAUNCH "HEART FRIENDLY™ DENTIST" AND SUPPORT THE
HEART & STROKE FOUNDATION DURING "HEART MONTH". In December 2012, Biosign acquired the assets of Bioanalytics Inc (see
press release dated December 7th, 2012) including the brand name "Heart Friendly™" and associated
The Company announced the re-launch of the Heart Friendly™ Dentist program in Ontario. Dentists who enroll in the Heart Friendly™ Dentist
program typically purchase a Biosign Pulsewave™ monitor for each exam
room or dental hygiene station, and then also pay a monthly or annual
fee for Biosign's Cloud Diagnostics™ readings and a free, printable Heart Friendly™ Health Report that they can print for each patient to take home. Dentists have
commented that the Heart Friendly™ program gives them an additional
valuable service to offer their patients, helps them differentiate
their practice from their competition, and even assists them in
identifying patients at immediate risk who may need medical attention.
In a brief test-market campaign in 2012, Bioanalytics enrolled over 50
Toronto-area clinics in the Heart Friendly™ program, and many of these
customers are now renewing their enrollment agreements with Biosign for
either one or two year commitments.
During Heart Month (February 2013) Biosign has agreed to donate 5% of
the net proceeds from each Toronto-area enrollment in the Heart
Friendly™ Dentist program to the Heart & Stroke Foundation. Additionally, Heart Friendly™ Dentists will be able to distribute
timely information from the Heart & Stroke Foundation to their patients
along with a Heart Friendly™ Health Report, powered by Biosign.
DOMINION MEDICAL SUPPLY COMMENTS: Dominion co-founder Ms. Pam Wellings stated: "Dominion Medical is
pleased to join Biosign as their sales agent to relaunch the Heart
Friendly™ Dentist program in Ontario, particularly during Heart Month.
Many dentist and hygienist customers are embracing the Heart Friendly™
approach to screening their patients, and dental customers appreciate
receiving a Heart Friendly™ Health Report as a valuable part of their
dental experience. We look forward to expanding the Heart Friendly
program to other provinces we cover, including the Maritimes and
Quebec, in the coming months."
MANAGEMENT COMMENTS: Biosign's CEO Mr. Robert Kaul commented: "Since our last Investor
Update the Biosign team has continued to execute our recovery plan with
excellent results. We have successfully added staff and channel
distribution resources to execute revenue generation strategies,
secured funding commitments to stabilize our finances, and refreshed
our marketing materials. The re-launch of the Heart Friendly™ Dentist program along with an opportunity to support the Heart & Stroke
Foundation is an important component of these renewed sales efforts,
and the results, measured in the number of Dental Clinic customers that
are re-enrolling after the 2012 market trial have been encouraging."
About Biosign Technologies Inc.
Biosign Technologies Inc. (TSXV: BIO) provides automated, computer
enabled health information products. Key applications include the
noninvasive monitoring of vital signs including blood pressure, pulse
rate and breathing rate, enhanced with web services. The Company's
Pulsewave™ medical device technology powers data collection for
clinical decision support, self-care, wellness and disease management,
while it's Healthanywhere™ software suite offers industry-leading
remote patient monitoring solutions. The Company offers a number of
cardiovascular screening programs for consumers under its Heart
Friendly™ brand, including Heart Friendly™ Dentist. For more
information on Biosign, please visit www.biosign.com
This release contains forward-looking statements. Forward-looking
statements, without limitation, may contain the words believes,
expects, anticipates, estimates, intends, plans, or similar
expressions. Forward-looking statements are not guarantees of future
performance. They involve risks, uncertainties and assumptions and
Biosign's actual results could differ materially from those
anticipated. Forward looking statements are based on the opinions and
estimates of management at the date the statements are made, and are
subject to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from those
projected in the forward-looking statements. In the context of any
forward-looking information please refer to risk factors detailed in,
as well as other information contained in, Biosign's filings with
Canadian securities regulators (www.sedar.com).
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
SOURCE: Biosign Technologies Inc.
For further information:
Biosign Contact Information
Chief Executive Officer
Phone: (416) 218-9800 ext. 201